Gulati, Payal
Singhal, Richa
Gupta, Apoorv
Anjali,
Tripathi, Praveen Kumar
Kumar, Dewesh
Sinha, Diamond Prakash
Singh, S. P.
Singh, Khileshwar
Baharia, Rajendra Kumar
Bhatt, K. N.
Vasava, Ashvin H.
Gamit, Amit
Patki, Manoj B.
Malla, Waseem A.
Kori, Lokesh
Savargaonkar, Deepali
Chakma, Nibir
Parmar, Daksh
Alagesan, Lenin
Kashyap, Ritika
Singh, Kuldeep
Anvikar, Anup R.
Bharti, Praveen K.
Nitika, Nitika
Funding for this research was provided by:
Indian Council of Medical Research (VBD/NIMR/Intra/0012/CD-II)
Article History
Received: 10 February 2026
Accepted: 10 April 2026
First Online: 7 May 2026
Declarations
:
: The Indian Council of Medical Research- National Institute of Malaria Research (ICMR-NIMR) Institutional Ethics Committee (IEC) has provided the approval for the study (NIMR/IEC-M/2023/970/v6-Jun/01). In addition, the approval has also been sought for other four study sites . This clinical trial study has received ethical approval from the IEC–Zoram Medical College and Hospital Mizoram; IEC–Late Baliram Kashyap Medical College, Chhattisgarh; IEC–RIMS, Ranchi, Jharkhand; Human Research Ethics Committee, Government Medical College, Surat, Gujarat. The trial is registered with Clinical Trial Registry of India (CTRI) with CTRI Registration details: CTRI/2025/07/091988. Written informed consent is taken from all the participants who are willing to voluntarily adhere to the trial protocol and to be a part of the study for 28 days follow up period. Those who are not willing to provide the consent are referred to hospital and given treatment as per National treatment guidelines.
: Not Applicable.
: The authors declare no competing interests.